Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing

In the UK, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medicines”. The purpose of the consultation was to help finalise t...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Martin, Couturier, Dominique-Laurent, Choodari-Oskooei, Babak, Crout, Phillip, Gamble, Carrol, Jacko, Peter, Pallmann, Philip, Pilling, Mark, Robertson, David S., Robling, Michael, Sydes, Matthew R., Villar, Sofía S., Wason, James, Wheeler, Graham, Williamson, S. Faye, Yap, Christina, Jaki, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552399/
https://www.ncbi.nlm.nih.gov/pubmed/37798805
http://dx.doi.org/10.1186/s13063-023-07576-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552399/
https://www.ncbi.nlm.nih.gov/pubmed/37798805
http://dx.doi.org/10.1186/s13063-023-07576-7

Ejemplares similares